Literature DB >> 12496166

4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniae.

Zheng-Qi Wu1, Abdul Q Khan, Yi Shen, Karen M Wolcott, Wojciech Dawicki, Tania H Watts, Robert S Mittler, Clifford M Snapper.   

Abstract

4-1BB (CD137) is induced on activated CD4(+) and CD8(+) T cells and delivers a costimulatory signal upon binding the 4-1BB ligand (4-1BBL) expressed on antigen-presenting cells. Induction of 4-1BB is dependent on activation via the T-cell receptor (TCR) and possibly CD28. It was previously demonstrated that both an in vivo protein (pneumococcal surface protein A [PspA])- and polysaccharide (phosphorylcholine [PC] determinant of teichoic acid)-specific immunoglobulin (Ig) isotype response to Streptococcus pneumoniae was dependent on CD4(+) TCRalphabeta(+) T cells and B7-dependent costimulation through CD28. We thus postulated that 4-1BB costimulation would also play a role in regulating the in vivo anti-PspA and anti-PC response to S. pneumoniae. We demonstrate that mice genetically deficient in 4-1BBL elicit a markedly reduced IgM and IgG anti-PC but normal primary and secondary IgG anti-PspA responses to S. pneumoniae relative to those for wild-type mice. However, injection of an agonistic anti-4-1BB monoclonal antibody (MAb), while having no significant effect on the anti-PC response, strongly inhibits the primary anti-PspA response, the generation of PspA-specific memory, and germinal center formation but does not induce a lasting state of tolerance. In contrast, anti-4-1BB MAb has no effect on the anti-PspA response when injected only at the time of secondary immunization. Delay of the addition of anti-4-1BB leads to progressively less inhibition of the primary response up to day 8. This inhibition is independent of CD8(+) T cells and is associated with the expansion of CD4(+) T cells with an activated phenotype, which is partly dependent on B7-dependent costimulation. These data are the first to suggest a stimulatory role for endogenous 4-1BB-4-1BBL interactions during a humoral immune response to a pathogen and further underscore significant differences in costimulation requirements for an in vivo protein- versus polysaccharide-specific Ig isotype response to an extracellular bacterium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496166      PMCID: PMC143421          DOI: 10.1128/IAI.71.1.196-204.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

2.  CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling.

Authors:  J Langstein; J Michel; J Fritsche; M Kreutz; R Andreesen; H Schwarz
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

3.  Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells.

Authors:  N R Chu; M A DeBenedette; B J Stiernholm; B H Barber; T H Watts
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

4.  In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions.

Authors:  Z Q Wu; Q Vos; Y Shen; A Lees; S R Wilson; D E Briles; W C Gause; J J Mond; C M Snapper
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

5.  4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells.

Authors:  K E Pollok; Y J Kim; J Hurtado; Z Zhou; K K Kim; B S Kwon
Journal:  Eur J Immunol       Date:  1994-02       Impact factor: 5.532

6.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

7.  Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor.

Authors:  Z Razi-Wolf; F Galvin; G Gray; H Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

8.  Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28.

Authors:  J C Hurtado; S H Kim; K E Pollok; Z H Lee; B S Kwon
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

9.  Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy.

Authors:  R S Mittler; T S Bailey; K Klussman; M D Trailsmith; M K Hoffmann
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

10.  CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.

Authors:  K Saoulli; S Y Lee; J L Cannons; W C Yeh; A Santana; M D Goldstein; N Bangia; M A DeBenedette; T W Mak; Y Choi; T H Watts
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

View more
  8 in total

Review 1.  T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.

Authors:  A Jeurissen; J L Ceuppens; X Bossuyt
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

Review 2.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection.

Authors:  Sang-C Lee; Seong-A Ju; Ha-N Pack; Sook-K Heo; Jae-H Suh; Sang-M Park; Boem-K Choi; Byoung S Kwon; Byung S Kim
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity.

Authors:  Fernando Souza-Fonseca-Guimaraes; Stephen J Blake; Amani Makkouk; Cariad Chester; Holbrook E Kohrt; Mark J Smyth
Journal:  Oncoimmunology       Date:  2016-06-30       Impact factor: 8.110

5.  Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent.

Authors:  Benyue Zhang; Charles H Maris; Juergen Foell; Jason Whitmire; Liguo Niu; Jing Song; Byoung S Kwon; Anthony T Vella; Rafi Ahmed; Joshy Jacob; Robert S Mittler
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

Review 6.  4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity.

Authors:  Todd Bartkowiak; Michael A Curran
Journal:  Front Oncol       Date:  2015-06-08       Impact factor: 6.244

Review 7.  The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity.

Authors:  Beom K Choi; Hyeon-Woo Lee
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

Review 8.  4-1BB: A promising target for cancer immunotherapy.

Authors:  Alyssa Min Jung Kim; Macy Rose Nemeth; Seung-Oe Lim
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.